📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Alnara Pharmaceuticals

1.1 - Company Overview

Alnara Pharmaceuticals Logo

Alnara Pharmaceuticals

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of orally delivered protein therapeutics for metabolic diseases, developing GI-targeted protein therapies designed to act in the gastrointestinal tract without being absorbed into the bloodstream.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Alnara Pharmaceuticals

Ocera Therapeutics Logo

Ocera Therapeutics

HQ: United States Website
  • Description: Provider of novel therapeutics in development for patients with acute and chronic liver disease, as a clinical-stage biopharmaceutical company focused on development and commercialization in an area of high unmet medical need; HE clinical development includes a recently completed Phase 2b trial, STOP-HE, which evaluated safety.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Ocera Therapeutics company profile →
Standard Bariatrics Logo

Standard Bariatrics

HQ: United States Website
  • Description: Provider of surgical instruments for weight-loss surgeries, focused on sleeve gastrectomy. Offerings include Titan SGS, a surgical stapler with a 23 cm continuous staple line for consistent sleeve anatomy; Standard Precision Bougie Device for precise alignment and protection of the incisura angularis; Standard Trocar, a bladeless access device for introducing Titan SGS; and Standard Clamp to plan and hold the staple line, helping standardize technique and improve efficiency.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Standard Bariatrics company profile →
CymaBay Logo

CymaBay

HQ: United States Website
  • Description: Provider of clinical-stage biopharmaceutical development and commercialization of proprietary new medicines for important human diseases, including Seladelpar—an investigational treatment for primary biliary cholangitis—and PBC-focused clinical trials such as IDEAL, AFFIRM, PBC with Hepatic Impairment, ASSURE, and RESPONSE.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CymaBay company profile →
Jecure Therapeutics Logo

Jecure Therapeutics

HQ: United States Website
  • Description: Provider of research and development focused on the discovery of innovative therapeutics for the treatment of non-alcoholic steatohepatitis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Jecure Therapeutics company profile →
Nexus BioPharma Logo

Nexus BioPharma

HQ: United States Website
  • Description: Provider of preclinical-stage biotechnology research and development focused on developing new therapies and intellectual property.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Nexus BioPharma company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Alnara Pharmaceuticals

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Alnara Pharmaceuticals

2.2 - Growth funds investing in similar companies to Alnara Pharmaceuticals

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Alnara Pharmaceuticals

4.2 - Public trading comparable groups for Alnara Pharmaceuticals

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Alnara Pharmaceuticals

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Alnara Pharmaceuticals

What does Alnara Pharmaceuticals do?

Alnara Pharmaceuticals is a provider of orally delivered protein therapeutics for metabolic diseases, developing GI-targeted protein therapies designed to act in the gastrointestinal tract without being absorbed into the bloodstream.

Who are Alnara Pharmaceuticals's competitors?

Alnara Pharmaceuticals's competitors and similar companies include Ocera Therapeutics, Standard Bariatrics, CymaBay, Jecure Therapeutics, and Nexus BioPharma.

Where is Alnara Pharmaceuticals headquartered?

Alnara Pharmaceuticals is headquartered in United States.

How many employees does Alnara Pharmaceuticals have?

Alnara Pharmaceuticals has 1,000 employees 🔒.

When was Alnara Pharmaceuticals founded?

Alnara Pharmaceuticals was founded in 2010 🔒.

What sector and industry vertical is Alnara Pharmaceuticals in?

Alnara Pharmaceuticals is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Alnara Pharmaceuticals

Who are the top strategic acquirers in Alnara Pharmaceuticals's sector and industry

Top strategic M&A buyers and acquirers in Alnara Pharmaceuticals's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Alnara Pharmaceuticals?

Top strategic M&A buyers groups and sectors for Alnara Pharmaceuticals include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Alnara Pharmaceuticals's sector and industry vertical

Which are the top PE firms investing in Alnara Pharmaceuticals's sector and industry vertical?

Top PE firms investing in Alnara Pharmaceuticals's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Alnara Pharmaceuticals's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Alnara Pharmaceuticals's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Alnara Pharmaceuticals's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Alnara Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Alnara Pharmaceuticals's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Alnara Pharmaceuticals?

The key public trading comparables and valuation benchmarks for Alnara Pharmaceuticals include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Alnara Pharmaceuticals for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Alnara Pharmaceuticals with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Alnara Pharmaceuticals's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Alnara Pharmaceuticals with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Alnara Pharmaceuticals's' sector and industry vertical?

Access recent funding rounds and capital raises in Alnara Pharmaceuticals's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Alnara Pharmaceuticals